Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Oom, Aaron L ^a   Smith, Davey ^a   Akrami, Kevan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; NS1 PROTEIN, DENGUE VIRUS TYPE 2; NS1 PROTEIN, ZIKA VIRUS; PEPTIDE FRAGMENT; VIRAL PROTEIN;

DENGUE; DENGUE VIRUS; HUMAN; IMMUNOLOGY; PROCEDURES; SEROLOGY; VIROLOGY; ZIKA FEVER; ZIKA VIRUS;

DENGUE; DENGUE VIRUS; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; PEPTIDE FRAGMENTS; SEROLOGIC TESTS; VIRAL NONSTRUCTURAL PROTEINS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85025824379     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-05980-z     Document Type: Article

References (51)

1. Dick, G. W., Kitchen, S. F. & Haddow, A. J. Zika virus (I). isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46, 509-520 (1952).
2. Musso, D. & Gubler, D. J. Zika virus. Clin. Microbiol. Rev. 29, 487-524 (2016).
3. Iovine, N. et al. Coinfection with Zika and Dengue-2 viruses in a traveler returning from Haiti, 2016: clinical presentation and genetic analysis. Clin. Infect. Dis. 64, 72-75 (2016).
4. Adiga, R. Phylogenetic analysis of the NS5 gene of Zika virus. J. Med. Virol. 88, 1821-1826 (2016).
5. Lanciotti, R. S., Lambert, A. J., Holodniy, M., Saavedra, S. & Signor, LdelC. C. Phylogeny of Zika virus in western hemisphere, 2015. Emerg. Infect. Dis. 22, 933-935 (2016).
6. Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat. Immunol. 17, 1102-1108 (2016).
7. Priyamvada, L. et al. Human antibody responses after Dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl. Acad. Sci. USA 113, 7852-7857 (2016).
8. Bhatt, S. et al. The global distribution and burden of dengue. Nature. 496, 504-507 (2013).
9. de Teive e Argolo, A. F. L. et al. High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil. BMC Infect. Dis. 16, 546, doi: 10.1186/s12879-016-1867-6 (2016).
10. Wong, S. J. et al. A multiplex microsphere immunoassay for Zika virus diagnosis. EBioMed.; j.ebiom.2017.01.008 (2017).
11. Piedrahita, L. D. et al. Evaluation of commercially available assays for diagnosis of acute dengue in schoolchildren during an epidemic period in Medellin, Colombia. Am. J. Trop. Med. Hyg. 95, 315-321 (2016).
12. Lohia, N. & Baranwal, M. Identification of conserved peptides comprising multiple T cell epitopes of Matrix 1 protein in H1N1 influenza virus. Viral Immunol. 28, 570-579 (2015).
13. Brinck-Jensen, N.-S., Vorup-Jensen, T., Leutscher, P. D. C., Erikstrup, C. & Petersen, E. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV. BMC Immunol. 16, doi: 10.1186/s12865-015-0127-7 (2015).
14. Devasundaram, S., Deenadayalan, A. & Raja, A. In silico analysis of potential human T cell antigens from Mycobacterium tuberculosis for the development of subunit vaccines against tuberculosis. Immunol. Invest. 43, 137-159 (2014).
15. Eirin, M. E. et al. Identification and evaluation of new Mycobacterium bovis antigens in the in vitro interferon gamma release assay for bovine tuberculosis diagnosis. Tuberculosis 95, 795-801 (2015).
16. Liu, Y., Liu, J. & Cheng, G. Vaccines and immunization strategies for dengue prevention. Emerg. Microbes Infect. 5, e77, doi: 10.1038/emi.2016.74 (2016).
17. Mathew, A. et al. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J. Clin. Invest. 98, 1684-1691 (1996).
18. Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science. 353, 823-826 (2016).
19. Steinhagen, K. et al. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with Dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Eurosurveillance 21, doi: 10.2807/1560-7917.ES.2016.21.50.30426 (2016).
20. Xu, X. et al. Contribution of intertwined loop to membrane association revealed by Zika virus full-length NS1 structure. EMBO. J. 35, 2170-2178 (2016).
21. Brister, J. R. et al. Virus variation resource - recent updates and future directions. Nucleic Acids Res 42, D660-665, doi: 10.1093/nar/gkt1268 (2014).
22. Pickett, B. E. et al. ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res. 40, D593-598, doi: 10.1093/nar/gkr859 (2012).
23. Calis, J. J. A. et al. Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Comput. Biol. 8, e1003266, doi: 10.1371/journal.pcbi.1003266 (2013).
24. Rossjohn, J. et al. T cell antigen receptor recognition of antigen-presenting molecules. Annu. Rev. Immunol. 33, 169-200 (2015).
25. Dikhit, M. R. et al. Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: a first step towards vaccine development. Infect. Genet. Evol. 45, 187-197 (2016).
26. Dar, H. et al. Prediction of promiscuous T-cell epitopes in the Zika virus polyprotein: an in silico approach. Asian Pac. J. Trop. Med. 9, 844-850 (2016).
27. Oyarzun, P., Ellis, J. J., Boden, M. & Kobe, B. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II protein diversity. BMC Bioinformatics 14, doi: 10.1186/1471-2105-14-52 (2013).
28. Soo, K.-M., Khalid, B., Ching, S.-M. & Chee, H.-Y. Meta-analysis of dengue severity during infection by different dengue virus serotypes in primary and secondary infections. PLoS ONE 11, e0154760, doi: 10.1371/journal.pone.0154760 (2016).
29. Bardina, S. V. et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science. 356, 175-180 (2017).
30. Pauvolid-Corrêa, A. et al. Nhumirim virus, a novel flavivirus isolated from mosquitoes from the Pantanal, Brazil. Arch. Virol. 160, 21-27 (2015).
31. Sahadeo, N. S. D. et al. Understanding the evolution and spread of chikungunya virus in the Americas using complete genome sequences. Virus Evol. 3, 1-10 (2017).
32. Halstead, S. B. Critique of World Health Organization recommendation of a Dengue vaccine. J. Infect. Dis. 214, 1793-1795 (2016).
33. Aguiar, M., Halstead, S. B. & Stollenwerk N. Consider stopping dengvaxia administration without immunological screening. Expert Rev. Vaccines., doi: 10.1080/14760584.2017.1276831 (2016).
34. Kearse, M. et al. Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28, 1647-1649 (2012).
35. Vita, R. et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 43, D405-412, doi: 10.1093/nar/gku938 (2015).
36. Moutaftsi, M. et al. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol. 24, 817-819 (2006).
37. Wang, P. et al. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput. Biol. 4, e1000048, doi: 10.1371/journal.pcbi/1000048 (2008).
38. Wang, P. et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics. 11, 568, doi: 10.1186/1471-2105-11-568 (2010).
39. Paul, S. et al. HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity. J. Immunol. 191, 5831-5839 (2013).
40. Weiskopf, D. et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc. Natl. Acad. Sci. USA 110, E2046-2053, doi: 10.1073/pnas.1305227110 (2013).
41. Greenbaum, J. et al. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 63, 325-335 (2011).
42. Giguère, S. et al. MHC-NP: predicting peptides naturally processed by the MHC. J. Immunol. Methods. 400-401, 30-36 (2013).
43. Bui, H. H. et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics. 7, 153, doi: 10.1186/1471-2105-7-153 (2006).
44. Duhovny D., Nussinov R. & Wolfson H. J. Efficient unbound docking of rigid molecules in Algorithms in Bioinformatics. WABI 2002. Lecture Notes in Computer Science, vol 2452 (eds. Guigó, R., Gusfield, D.) 185-200 (Springer, 2002).
45. Schneidman-Duhovny, D., Inbar, Y., Nussinov, R. & Wolfson, H. J. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucl. Acids. Res. 33, W363-367 (2005).
46. Singh, S. et al. PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues. Biol. Dir. 10, 73, doi: 10.1186/s13062-015-0103-4 (2015).
47. Kaur, H., Garg, A. & Raghava, G. P. S. PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides. Protein. Pept. Lett. 14, 626-631 (2007).
48. Hillig, R. C. et al. High-resolution structure of HLA-A∗0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene. J. Mol. Biol. 310, 1167-1176 (2001).
49. McMahon, R. M. et al. Structure of Hla-A0301 in complex with a peptide of proteolipid protein: insights into the role of Hla-A alleles in susceptibility to multiple sclerosis. Acta Crystallogr. Sect. D. 67, 447-454 (2011).
50. Roder, G. et al. Crystal structures of two peptide-HLA-B∗1501 complexes; structural characterization of the HLA-B62 supertype. Acta Crystallogr. Sect. D. 62, 1300-1310 (2006).
51. Gras, S. et al. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc. Natl. Acad. Sci. USA 107, 12599-12604 (2010).